Seckin O. Ulualp

Professor

University of Texas Southwestern Medical Center
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (18)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Objectives To identify the prevalence and polysomnography (PSG) features of obstructive sleep apnea (OSA) in subcategories of children with obesity. Methods Children with obstructive sleep‐disordered breathing evaluated in pediatric otolaryngology clinic and referred for PSG between January 2023 and December 2023 were included. Children with a history of tonsillectomy and/or adenoidectomy were excluded. Collected data included demographics, comorbidities, PSG parameters, and BMI categories including underweight, healthy weight, overweight, and obesity (Class I, II, and III). The prevalence of OSA and PSG parameters were compared using the χ 2 test, logistic regression, multivariate analysis of variance, and linear regression models. p 10). PSG parameters including obstructive apnea‐hypopnea index, minimum SpO 2 , and mean CO 2 differed among BMI categories ( p < 0.001, p < 0.001, p = 0.003, respectively). Conclusion The prevalence of OSA varies among weight groups. The severity of obesity is associated with increased odds of OSA and OSA severity. Obesity has a significant effect on minimum SpO 2 saturation and mean CO 2 levels. The utility of these findings in decision‐making for PSG referral and surgical planning merits further investigation. Level of Evidence 4.

Year:

2026

Year:

2026

Year:

2025

Objectives To determine the prevalence of periodic limb movements (PLMS) in children with obstructive sleep apnea (OSA) and assess the effect of adenotonsillectomy (AT) on PLMS. Methods Charts of children with OSA who underwent AT were reviewed for demographics, obstructive apnea‐hypopnea index, and PLMS before and after AT. Prevalence of elevated periodic limb movement index (PLMI), defined as PLMS > 5 events/h, was compared with χ 2 test or Fisher's exact. Paired t ‐test and Wilcoxon signed rank test were used to compare PLMI pre‐and post‐AT. Results Elevated PLMI occurred in 114 (9.8%) of 1159 children (676 male,483 female, median age = 5). The prevalence of elevated PLMI was similar in gender, ethnicity, race, and weight categories. Compared to toddlers, the odds of elevated PLMI increased 22.1 times in preschoolers ( p ≤ 0.001), 35.4 times in grade‐schoolers ( p ≤ 0.001), and 30.8 times in teenagers ( p ≤ 0.001). Compared to children with mild OSA, the odds of elevated PLMI increased 2.3 times in children with moderate OSA ( p = 0.007) and 1.9 times in those with severe OSA ( p = 0.01). Of the 54 children who had a polysomnogram after AT, 46 (85%) resolved and 8 (15%) had persistent elevated PLMI. PLMI after AT decreased from 11.9 ± 7.6 to 2.9 ± 6.5 ( p ≤ 0.001). Conclusions Elevated PLMI is common in children with OSA undergoing AT. PLMI resolves after AT in most children with OSA. Level of Evidence: 4.

Year:

2025

Objectives To determine the prevalence of positional obstructive sleep apnea (pOSA) in children undergoing adenotonsillectomy (AT) for OSA and to assess whether pOSA improves following AT. Materials and Methods Children with OSA diagnosed by polysomnography (PSG) at a tertiary care children's hospital were included. Data was collected on demographics, PSG parameters, and surgical management. Statistical comparisons between groups for the prevalence of pOSA were performed with the χ2 test or Fisher's exact test, for PSG parameters prior to AT with Student's t ‐test or Mann–Whitney Rank Sum Test, and for PSG parameters before and after AT with paired t‐test and Wilcoxon Signed Rank Test. p < 0.05 was considered significant. Results Of the 1167 children (682 male, 485 female, median age = 5.7 years), 321 (28%) had pOSA. POSA children (median age = 7.4 years) were older than children with no pOSA (median = 5.2) ( p ≤ 0.001). The prevalence of pOSA in the subgroups of gender and weight was not different. The prevalence of pOSA was significantly different amongst the race groups ( p = 0.005). Compared with the Black/African American race, the white race had 1.4 times the odds of pOSA (95% CI, 1.07–1.98). The prevalence of pOSA was not significantly different between mild, moderate, and severe OSA groups ( p = 0.7). Of the 66 POSA children who had PSG pre‐ and post‐TA, 50 (76%) had resolution of pOSA. Children older than 6 years of age and children with obesity had a higher rate of persistent pOSA ( p = 0.02 and p = 0.008, respectively). Conclusion POSA occurred frequently in OSA children undergoing AT. POSA is resolved in the majority of children after AT. Persistent pOSA was more prevalent in older and obese children. AT is used as the first‐line treatment for pOSA in children. Future studies are needed to determine the role of positional therapy and other OSA therapies in the management of persistent pOSA after AT. Level of Evidence 4.

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Collaborators (2)

Romaine Johnson

MD/MPH Program Director

University of Texas Southwestern Medical Center

UNITED STATES
View details

Christopher Liu

University of Texas Southwestern Medical Center

UNITED STATES
View details